Lifeclean Q1’21: Pandemic affected more than Expected

Redeye's view on the Q1 report. The outcome of the first quarter was weaker than we expected. The acquisitions are now included, leading to some adjustments on the balance sheet and higher costs than we expected. The long-term case is intact with excellent growth prospects even if the short-term uncertainty is higher than we anticipated before the report.

We maintain our long-term positive view and a fair value in our Base case of SEK 16 per share..